EGFR levels, activation status and heterodimerization all influence the in vivo antitumor activity of EGFR-specific antibodies in glioma Conference Paper uri icon

authors

  • Johns, TG
  • Perera, RM
  • Luwor, RB
  • Cavenee, WK
  • Scott, AM
  • Furnari, FB

publication date

  • October 1, 2006